Cinepazidemaleate

CAS : 26328-04-1

Ref. 3D-FC149837

Informations sur le produit

• Nom: Cinepazidemaleate
• Synonymes: (E)-1-[4-(2-oxo-2-pyrrolidin-1-yl-ethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, (Z)-but-2-enedioate, 1-((1-Pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine maleate, 1-(2-Oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)piperazine (Z)-2-butenedioate (1:1), 1-(2-Oxo-2-pyrrolidin-1-ylethyl)-4-(3-(3,4,5-trimethoxyphenyl)acryloyl)piperazine monomaleate, 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazine (2Z)-but-2-enedioate, 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[3-(3,4,5-trimethoxyphenyl)acryloyl]piperazine (2Z)-but-2-enedioate, 1-(4-((3',4',5'-Trimethoxycinnamoyl)-1-piperazinyl)acetyl)pyrrolidine maleate, 2-Propen-1-one, 1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-, (2Z)-2-butenedioate (1:1), 4-(3,4,5-Trimethoxycinnamoyl)-1-(1-pyrrolidinyl)carbonylmethylpiperazine maleate, Brendil, Maleate de cinepazide, Maleate de cinepazide [French], Md 67350, Nsc 291562, Piperazine, 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3',4',5'-trimethoxycinnamoyl)-, maleate, Piperazine, 1-(2-oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, (Z)-2-butenedioate (1:1) (9CI), Piperazine, 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-, maleate (1:1), Piperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-, (2Z)-2-butenedioate (1:1), Piperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-, (Z)-2-butenedioate (1:1), Vasodistal
• CAS: 26328-04-1

Description

Cinepazidemaleate is a drug used for the treatment of cerebral and coronary heart diseases. It acts as an inhibitor of neuronal death, which occurs when the cells of the brain are deprived of oxygen and glucose. Cinepazidemaleate inhibits mitochondrial functions by blocking ATP production in cellular mitochondria, thereby preventing energy metabolism. This inhibition leads to an increase in basic proteins that can be detected in animal models. Studies have shown that cinepazidemaleate is more effective when combined with other drugs such as piperazine maleate or glucose injection. These studies suggest that cinepazidemaleate may be useful for treating people with cerebral and coronary heart diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 533.57 g/mol
• Formule: C₂₆H₃₅N₃O₉
• Degré de pureté: Min. 95%